14-59510684-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001164399.2(CCDC175):c.2267G>A(p.Arg756His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000185 in 1,537,196 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001164399.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC175 | NM_001164399.2 | c.2267G>A | p.Arg756His | missense_variant | 19/20 | ENST00000537690.7 | NP_001157871.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC175 | ENST00000537690.7 | c.2267G>A | p.Arg756His | missense_variant | 19/20 | 5 | NM_001164399.2 | ENSP00000453940.1 | ||
CCDC175 | ENST00000281581.5 | c.2267G>A | p.Arg756His | missense_variant | 19/20 | 5 | ENSP00000452964.1 | |||
CCDC175 | ENST00000553317.1 | n.30G>A | non_coding_transcript_exon_variant | 1/3 | 3 | |||||
ENSG00000258782 | ENST00000554253.1 | n.428G>A | non_coding_transcript_exon_variant | 4/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000898 AC: 13AN: 144720Hom.: 0 AF XY: 0.0000907 AC XY: 7AN XY: 77196
GnomAD4 exome AF: 0.000191 AC: 264AN: 1384912Hom.: 1 Cov.: 31 AF XY: 0.000183 AC XY: 125AN XY: 683364
GnomAD4 genome AF: 0.000131 AC: 20AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74458
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at